Gene-network analysis is a valuable new tool for understanding Alzheimer's disease

April 14, 2020

Osaka, Japan -- Alzheimer's disease (AD) is known to involve interactions among many different genes, making it difficult to pinpoint the specific mechanisms. But now, researchers from Japan have found a new way to identify genes implicated in neurodegeneration in AD.

In a study published this month in Human Molecular Genetics, researchers from Osaka University, Niigata University, and the National Center for Geriatrics and Gerontology have revealed genes that trigger specific changes in connections between proteins, called protein domain networks (PDNs), that are significantly associated with neurodegeneration in AD.

Network analysis is effective for identifying features of AD in humans, as well as identifying genes that control pathological changes in network properties. The researchers conducted network analysis of changes in PDNs to determine whether this process could be used to reveal genetic changes associated with AD pathology throughout the different stages of the disease.

"PDNs can vary widely among tissues and cell types and have different structures in normal versus disease states," explains Masataka Kikuchi, lead author of the study. "We wanted to see if we could use an integrated network approach to identify new genes associated with the collapse of PDNs in AD," adds Michiko Sekiya, co-lead author.

To do this, the researchers examined protein interaction data and gene expression data from postmortem brain samples from patients with AD to generate PDNs. They found that the deterioration of PDNs occurred at specific stages of AD and identified RAC1 as a specific gene that plays a key role in the alteration of PDNs. They then examined the effects of deactivating RAC1 in the fruit fly Drosophila.

"We found reduced levels of RAC1 in postmortem brain samples from patients with AD, and these changes were validated by gene expression levels from a publicly available data set" says senior author Koichi M. Iijima. "Further, inhibiting RAC1 in Drosophila induced age-dependent changes in behavior, accompanied by neurodegeneration."

In addition, they found that the number of interactions constituting PDNs in three regions from AD brains decreased with each stage of AD.

"These data provide further evidence that PDNs collapse during the progression of AD," says Norikazu Hara, co-lead author. "Thus, changes in PDNs may be a key element of neuronal dysfunction and neurodegeneration that occurs in AD."

These results indicate that an integrated network approach is advantageous in determining the factors that lead to neurodegeneration in AD, which may improve the chances of uncovering new biomarkers and therapeutic treatments.
-end-
The article, "Disruption of a RAC1-centred network is associated with Alzheimer's disease pathology and causes age-dependent neurodegeneration" was published in Human Molecular Genetics at DOI: https://doi.org/10.1093/hmg/ddz320

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan's leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan's most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university's ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Osaka University

Related Neurodegeneration Articles from Brightsurf:

Presented a program capable of detecting neurodegeneration biomarkers through magnetic
This tool is able to identify single-person neurodegeneration before the symptom's appearance, which could significate a more effective and personalized medicine.

Biomarker indicating neurodegeneration identified in the eye
A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye.

Nerve cells with energy saving program
Thanks to a metabolic adjustment, the cells can remain functional despite damage to the mitochondria.

Gene yields insights into the causes of neurodegeneration
Cornell researchers including Fenghua Hu, associate professor in the Department of Molecular Biology and Genetics and member of the Weill Institute for Cell and Molecular Biology, are taking a closer look at the factors that cause Alzheimer's, FTLD and similar diseases.

When astrocytes attack: Stem cell model shows possible mechanism behind neurodegeneration
A new study published today in Neuron led by The New York Stem Cell Foundation (NYSCF) Research Institute's Valentina Fossati, Ph.D., creates astrocytes - an integral support cell in the brain -- from stem cells and shows that in disease-like environments, these normally helpful cells can turn into neuron-killers.

Gene-network analysis is a valuable new tool for understanding Alzheimer's disease
Researchers from Osaka University, Niigata University, and the National Center for Geriatrics and Gerontology have found that disruption of protein domain networks that are driven by the RAC1 gene is associated with behavioral and neurological symptoms of Alzheimer's disease.

Buck researchers discover how cellular senescence leads to neurodegeneration
Although a link has been established between chronic inflammation and neurodegenerative diseases, there have been many open questions regarding how cellular senescence, a process whereby cells that stop dividing under stress spew out a mix of inflammatory proteins, affects these pathologies.

Protein associated with ovarian cancer exacerbates neurodegeneration in Alzheimer's
Houston Methodist scientists identified a protein found in ovarian cancer that may contribute to declining brain function and Alzheimer's disease, by combining computational methods and lab research.

Objective subtle cognitive difficulties predict amyloid accumulation and neurodegeneration
Researchers report that accumulating amyloid protein occurred faster among persons deemed to have 'objectively-defined subtle cognitive difficulties' (Obj-SCD) than among persons considered to be 'cognitively normal,' offering a potential new early biomarker for Alzheimer's disease.

KBRI team reduces neurodegeneration associated with dementia in animal models
Korean research team made up of Dr. Hyung-Jun Kim and Shinrye Lee of KBRI, and professor Kiyoung Kim of Soonchunhyang University, found a new molecular mechanism of suppressing neuronal toxicity associateded dementia and Lou Gehrig's disease.

Read More: Neurodegeneration News and Neurodegeneration Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.